CCM
BLFS icon

Chilton Capital Management’s BioLife Solutions BLFS Stock Holding History

Chilton Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-33
Closed -$798 – 672
2025
Q4 		$798 Buy
+33
New +$863 ﹤0.01% 605

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Chilton Capital Management's BLFS Position: Q1 2026 in Review

Chilton Capital Management sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 33 shares — an estimated $798 sold.

Chilton Capital Management first reported a position in BLFS in Q4 2025 and held it in 1 quarter. The position peaked at $798 in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Chilton Capital Management reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
  • Chilton Capital Management sold 33 BioLife Solutions shares in Q1 2026, an estimated $798.
  • Chilton Capital Management first reported a position in BioLife Solutions in Q4 2025 and held it in 1 quarter.
  • Chilton Capital Management's BioLife Solutions position peaked at $798 in Q4 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.